Health ❯ Healthcare ❯ Clinical Trials

Vaccine Trials

Efficacy Studies Triple-Negative Breast Cancer Phase 1 Trials Allergard Vaccine Trials Lung Cancer Vaccine Participant Recruitment Phase I Trials 21-Valent Vaccine Ovarian Cancer Vaccine Trials Late-stage Trials

4 ARTICLES

last wk.

KRAS Vaccine Elicits Durable Immune Response in People at High Risk for Pancreatic Cancer

Researchers report that a phase 1 trial found the vaccine to be safe and to produce long-lived mutation-specific T cells in most participants, prompting larger studies to test whether it can actually prevent cancer.

3 ARTICLES

last mo.

FDA Expands Capvaxive Use to At‑Risk Children and Teens

5 ARTICLES

last mo.

Oxford and Moderna Set to Launch Phase‑1 Trial of Preventive mRNA Vaccine for Lynch Syndrome

7 ARTICLES

3mo ago

Pfizer and BioNTech Halt U.S. COVID Vaccine Trial for 50–64-Year-Olds Over Slow Enrollment

3 ARTICLES

4mo ago

Pfizer–Valneva Lyme Vaccine Shows Over 70% Efficacy but Misses Primary Endpoint

3 ARTICLES

7mo ago

Biofabri, Bharat Biotech Sign MTBVAC Tech-Transfer Deal to Scale TB Vaccine Supply

4 ARTICLES

7mo ago

Final Phase I Data Show Preventive TNBC Vaccine Is Safe and Induces Immune Responses in Most Participants

6 ARTICLES

8mo ago

Vaxart's Oral Norovirus Vaccine Shows Promise in Early Trials for Elderly Adults

6 ARTICLES

2y ago

Scientists Near Breakthrough with Potential 'One-and-Done' Universal Flu Vaccine

Vaccine Trials

KRAS Vaccine Elicits Durable Immune Response in People at High Risk for Pancreatic Cancer

FDA Expands Capvaxive Use to At‑Risk Children and Teens

Oxford and Moderna Set to Launch Phase‑1 Trial of Preventive mRNA Vaccine for Lynch Syndrome

Pfizer and BioNTech Halt U.S. COVID Vaccine Trial for 50–64-Year-Olds Over Slow Enrollment

Pfizer–Valneva Lyme Vaccine Shows Over 70% Efficacy but Misses Primary Endpoint

Biofabri, Bharat Biotech Sign MTBVAC Tech-Transfer Deal to Scale TB Vaccine Supply

Final Phase I Data Show Preventive TNBC Vaccine Is Safe and Induces Immune Responses in Most Participants

Moderna Trims 2025 Forecast as Q3 Loss Narrows and Revenue Beats

MCRI Launches World-First Infant Trial of 21‑Valent Pneumococcal Vaccine

Moderna’s mRNA-1010 Flu Vaccine Shows Superior Efficacy in Phase 3 Trial

Vaxart's Oral Norovirus Vaccine Shows Promise in Early Trials for Elderly Adults

Scientists Near Breakthrough with Potential 'One-and-Done' Universal Flu Vaccine